BCHE and Parkinson disease: Identifying chalcone compounds inactivating monoamine oxidase and cholinesterase can be helpful in developing pharmaceuticals for various neuronal disorders, such as PD and AD, managing stress, neuroinflammation, etc., (Cesura, 2007; Chimenti et al., 2009).